In one paragraphArticle in Applied and environmental microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Jennifer K ParkerDepartment of Molecular Biosciences, The University of Texas at Austin, Austin, Texas, USA.ORCID 0000-0002-4382-0741 Leon P ToursarkissianDepartment of Molecular Biosciences, The University of Texas at Austin, Austin, Texas, USA.
Joanna R ChangDepartment of Molecular Biosciences, The University of Texas at Austin, Austin, Texas, USA.ORCID 0000-0001-5881-6780 Simon Sanchez-PaivaDepartment of Molecular Biosciences, The University of Texas at Austin, Austin, Texas, USA.ORCID 0009-0003-6355-1264 Angela C O'DonnellDepartment of Molecular Biosciences, The University of Texas at Austin, Austin, Texas, USA.ORCID 0000-0003-1408-5431 Halimot O BadmusDepartment of Molecular Biosciences, The University of Texas at Austin, Austin, Texas, USA.ORCID 0009-0007-9365-8993 Maria Patricia NunezDepartment of Microbiology & Immunology, Columbia University Irving Medical Center, New York, New York, USA.
Anne-Catrin UhlemannDivision of Infectious Diseases, Columbia University Irving Medical Center, New York, New York, USA.ORCID 0000-0002-9798-4768 Bryan W DaviesDepartment of Molecular Biosciences, The University of Texas at Austin, Austin, Texas, USA.ORCID 0000-0002-2046-0341 Funding
Investigating nanobodies to target multidrug resistant bacterial pathogensR01AI148419 · NIAID · UNIVERSITY OF TEXAS AT AUSTIN · PI DAVIES, BRYAN WILLIAM · 2020 to 2023
$2.8MVibrio microcins. A hidden field of targeted anti-cholerae natural products.R01AI182365 · NIAID · UNIVERSITY OF TEXAS AT AUSTIN · PI Bryan William Davies · 2024 to 2026
$2.2MFrom microcin sequence to function: linking sequence variation to antimicrobial activityR56AI179799 · NIAID · UNIVERSITY OF TEXAS AT AUSTIN · PI DAVIES, BRYAN WILLIAM · 2024 to 2024
$726kDelineating genetic determinants of polymyxin resistance in Serratia marcescensR21AI156727 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI UHLEMANN, ANNE-CATRIN · 2021 to 2022
$458kMultidisciplinary University Research Initiative ARO W911NF2010195National Institute of Food and Agriculture 2024-67013-42304NIAID NIH HHS R01 AI148419NIAID NIH HHS R01 AI182365NIAID NIH HHS R56 AI179799NIH HHS R01 AI148419NIH HHS R01 AI182365NIH HHS R21 AI156727NIH HHS R56 AI179799The Winkler Family FoundationTito's Handmade VodkaWelch Foundation F-2137
6 · The paper itselfAbstract
Indexed as
Anti-Bacterial AgentsBacteriocinsSerratia marcescensAnimalsGenome, BacterialMicrobial Sensitivity TestsAnti-Bacterial AgentsBacteriocinsmicrocinantibacterialbacteriocincompetitiongram-negativemicrocinsecretion
Identifiers
PMID41914898
PMCPMC13101503
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390